RT @NirUrielMD: Another nice publication on targets to aim for LV remodeling/recovery in HFrEF https://t.co/Q49SHGm5eS
NT-proBNP Goal Achievement Is Associated With Significant Reverse Remodeling and Improved Clinical Outcomes in HFrEF https://t.co/u2xYdBtA1p
RT @DukeHFDoc: With all due respect to my esteemed mentor and friend @coconnormd , hopefully well designed and conducted trials teach us st…
RT @coconnormd: NT-proBNP Goal Achievement Is Associated With Significant Reverse Remodeling and Improved Clinical Outcomes in HFrEF | JACC…
RT @DukeHFDoc: With all due respect to my esteemed mentor and friend @coconnormd , hopefully well designed and conducted trials teach us st…
With all due respect to my esteemed mentor and friend @coconnormd , hopefully well designed and conducted trials teach us stuff whether ostensibly positive or negative, and thus don't need to be "salvaged."😀
RT @coconnormd: NT-proBNP Goal Achievement Is Associated With Significant Reverse Remodeling and Improved Clinical Outcomes in HFrEF | JACC…
RT @coconnormd: NT-proBNP Goal Achievement Is Associated With Significant Reverse Remodeling and Improved Clinical Outcomes in HFrEF | JACC…
NT-proBNP Goal Achievement Is Associated With Significant Reverse Remodeling and Improved Clinical Outcomes in HFrEF | JACC: Heart Failure : Can additional analyses salvage GUIDE-IT? https://t.co/4MwPldCY0v
RT @paolabel_cardio: Podríamos decir que conseguir un Nt-proBNP<1000 al año de haber iniciado y titulado fármacos de primera línea nos info…
RT @JJheart_doc: An exceptionally important paper from the GUIDE IT trial. Misinterpretation of the GUIDE IT results has led to confusion…
RT @JJheart_doc: An exceptionally important paper from the GUIDE IT trial. Misinterpretation of the GUIDE IT results has led to confusion…
RT @JJheart_doc: An exceptionally important paper from the GUIDE IT trial. Misinterpretation of the GUIDE IT results has led to confusion…
RT @JJheart_doc: An exceptionally important paper from the GUIDE IT trial. Misinterpretation of the GUIDE IT results has led to confusion…
RT @JJheart_doc: An exceptionally important paper from the GUIDE IT trial. Misinterpretation of the GUIDE IT results has led to confusion…
RT @JJheart_doc: An exceptionally important paper from the GUIDE IT trial. Misinterpretation of the GUIDE IT results has led to confusion…
RT @JJheart_doc: An exceptionally important paper from the GUIDE IT trial. Misinterpretation of the GUIDE IT results has led to confusion…
RT @JJheart_doc: An exceptionally important paper from the GUIDE IT trial. Misinterpretation of the GUIDE IT results has led to confusion…
RT @JJheart_doc: An exceptionally important paper from the GUIDE IT trial. Misinterpretation of the GUIDE IT results has led to confusion…
RT @JJheart_doc: An exceptionally important paper from the GUIDE IT trial. Misinterpretation of the GUIDE IT results has led to confusion…
RT @JJheart_doc: An exceptionally important paper from the GUIDE IT trial. Misinterpretation of the GUIDE IT results has led to confusion…
RT @JJheart_doc: An exceptionally important paper from the GUIDE IT trial. Misinterpretation of the GUIDE IT results has led to confusion…
RT @JJheart_doc: An exceptionally important paper from the GUIDE IT trial. Misinterpretation of the GUIDE IT results has led to confusion…
RT @JJheart_doc: An exceptionally important paper from the GUIDE IT trial. Misinterpretation of the GUIDE IT results has led to confusion…
An exceptionally important paper from the GUIDE IT trial. Misinterpretation of the GUIDE IT results has led to confusion about how changes in NT-proBNP should be interpreted in chronic HF. These results illustrate just how important those changes are. h
RT @paomorejon: 📌NT-proBNP: Lograr objetivo 🔜 Mejores resultados 🌀Subestudio GUIDE-IT 🌀PRIDE-study estableció el punto de corte 🌀Terapia óp…
RT @ValleAlfonso: 📋GUIDE-IT Echo 1️⃣cambios FEVI;VTDVI similar en terapia habitual vs guiada por NTproBNP 2️⃣Reducción NT-proBNP<1000pg/ml…
RT @ValleAlfonso: 📋GUIDE-IT Echo 1️⃣cambios FEVI;VTDVI similar en terapia habitual vs guiada por NTproBNP 2️⃣Reducción NT-proBNP<1000pg/ml…
RT @ValleAlfonso: 📋GUIDE-IT Echo 1️⃣cambios FEVI;VTDVI similar en terapia habitual vs guiada por NTproBNP 2️⃣Reducción NT-proBNP<1000pg/ml…
RT @ValleAlfonso: 📋GUIDE-IT Echo 1️⃣cambios FEVI;VTDVI similar en terapia habitual vs guiada por NTproBNP 2️⃣Reducción NT-proBNP<1000pg/ml…
NT-proBNP Goal Achievement Is Associated With Significant Reverse Remodeling and Improved Clinical Outcomes in HFrEF | JACC: Heart Failure https://t.co/R1xZMDeFi8
RT @ValleAlfonso: 📋GUIDE-IT Echo 1️⃣cambios FEVI;VTDVI similar en terapia habitual vs guiada por NTproBNP 2️⃣Reducción NT-proBNP<1000pg/ml…
RT @ValleAlfonso: 📋GUIDE-IT Echo 1️⃣cambios FEVI;VTDVI similar en terapia habitual vs guiada por NTproBNP 2️⃣Reducción NT-proBNP<1000pg/ml…
RT @ValleAlfonso: 📋GUIDE-IT Echo 1️⃣cambios FEVI;VTDVI similar en terapia habitual vs guiada por NTproBNP 2️⃣Reducción NT-proBNP<1000pg/ml…
RT @paomorejon: 📌NT-proBNP: Lograr objetivo 🔜 Mejores resultados 🌀Subestudio GUIDE-IT 🌀PRIDE-study estableció el punto de corte 🌀Terapia óp…
RT @ValleAlfonso: 📋GUIDE-IT Echo 1️⃣cambios FEVI;VTDVI similar en terapia habitual vs guiada por NTproBNP 2️⃣Reducción NT-proBNP<1000pg/ml…
RT @ValleAlfonso: 📋GUIDE-IT Echo 1️⃣cambios FEVI;VTDVI similar en terapia habitual vs guiada por NTproBNP 2️⃣Reducción NT-proBNP<1000pg/ml…
RT @paolabel_cardio: Podríamos decir que conseguir un Nt-proBNP<1000 al año de haber iniciado y titulado fármacos de primera línea nos info…
RT @paomorejon: 📌NT-proBNP: Lograr objetivo 🔜 Mejores resultados 🌀Subestudio GUIDE-IT 🌀PRIDE-study estableció el punto de corte 🌀Terapia óp…
RT @ValleAlfonso: 📋GUIDE-IT Echo 1️⃣cambios FEVI;VTDVI similar en terapia habitual vs guiada por NTproBNP 2️⃣Reducción NT-proBNP<1000pg/ml…
RT @ValleAlfonso: 📋GUIDE-IT Echo 1️⃣cambios FEVI;VTDVI similar en terapia habitual vs guiada por NTproBNP 2️⃣Reducción NT-proBNP<1000pg/ml…
RT @paomorejon: 📌NT-proBNP: Lograr objetivo 🔜 Mejores resultados 🌀Subestudio GUIDE-IT 🌀PRIDE-study estableció el punto de corte 🌀Terapia óp…
RT @ValleAlfonso: 📋GUIDE-IT Echo 1️⃣cambios FEVI;VTDVI similar en terapia habitual vs guiada por NTproBNP 2️⃣Reducción NT-proBNP<1000pg/ml…
RT @ValleAlfonso: 📋GUIDE-IT Echo 1️⃣cambios FEVI;VTDVI similar en terapia habitual vs guiada por NTproBNP 2️⃣Reducción NT-proBNP<1000pg/ml…
Podríamos decir que conseguir un Nt-proBNP<1000 al año de haber iniciado y titulado fármacos de primera línea nos informa de un paciente “optimizado “! Necesitamos estos datos objetivos 👌🏻🤓
📋GUIDE-IT Echo 1️⃣cambios FEVI;VTDVI similar en terapia habitual vs guiada por NTproBNP 2️⃣Reducción NT-proBNP<1000pg/ml a 12m, independiente del brazo tratamiento,➡️mayor ⤵️VTDVI y ⤴️FEVI vía @JACCJournals 📎 https://t.co/lDF7QynQYD @secardiologia https
RT @paomorejon: 📌NT-proBNP: Lograr objetivo 🔜 Mejores resultados 🌀Subestudio GUIDE-IT 🌀PRIDE-study estableció el punto de corte 🌀Terapia óp…
RT @paomorejon: 📌NT-proBNP: Lograr objetivo 🔜 Mejores resultados 🌀Subestudio GUIDE-IT 🌀PRIDE-study estableció el punto de corte 🌀Terapia óp…
RT @paomorejon: 📌NT-proBNP: Lograr objetivo 🔜 Mejores resultados 🌀Subestudio GUIDE-IT 🌀PRIDE-study estableció el punto de corte 🌀Terapia óp…
RT @paomorejon: 📌NT-proBNP: Lograr objetivo 🔜 Mejores resultados 🌀Subestudio GUIDE-IT 🌀PRIDE-study estableció el punto de corte 🌀Terapia óp…
RT @paomorejon: 📌NT-proBNP: Lograr objetivo 🔜 Mejores resultados 🌀Subestudio GUIDE-IT 🌀PRIDE-study estableció el punto de corte 🌀Terapia óp…
RT @paomorejon: 📌NT-proBNP: Lograr objetivo 🔜 Mejores resultados 🌀Subestudio GUIDE-IT 🌀PRIDE-study estableció el punto de corte 🌀Terapia óp…
RT @paomorejon: 📌NT-proBNP: Lograr objetivo 🔜 Mejores resultados 🌀Subestudio GUIDE-IT 🌀PRIDE-study estableció el punto de corte 🌀Terapia óp…
RT @paomorejon: 📌NT-proBNP: Lograr objetivo 🔜 Mejores resultados 🌀Subestudio GUIDE-IT 🌀PRIDE-study estableció el punto de corte 🌀Terapia óp…
RT @paomorejon: 📌NT-proBNP: Lograr objetivo 🔜 Mejores resultados 🌀Subestudio GUIDE-IT 🌀PRIDE-study estableció el punto de corte 🌀Terapia óp…
RT @paomorejon: 📌NT-proBNP: Lograr objetivo 🔜 Mejores resultados 🌀Subestudio GUIDE-IT 🌀PRIDE-study estableció el punto de corte 🌀Terapia óp…
📌NT-proBNP: Lograr objetivo 🔜 Mejores resultados 🌀Subestudio GUIDE-IT 🌀PRIDE-study estableció el punto de corte 🌀Terapia óptima NT-proBNP ⬇️1000 🔂Mayor remodelado reverso🔀menos eventos adversos ⚠️Delta y menos de 1000. #cardiotwitter #heartfailure https://
RT @coconnormd: NT-proBNP Goal Achievement Is Associated With Significant Reverse Remodeling and Improved Clinical Outcomes in HFrEF | JACC…
RT @coconnormd: NT-proBNP Goal Achievement Is Associated With Significant Reverse Remodeling and Improved Clinical Outcomes in HFrEF | JACC…
RT @coconnormd: NT-proBNP Goal Achievement Is Associated With Significant Reverse Remodeling and Improved Clinical Outcomes in HFrEF | JACC…
RT @prabhud19: Among patients with HFrEF, lowering NT-proBNP to <1,000 pg/ml by 12 months was associated with significant reverse remodelin…
【HFrEF 268例ランダム化 [GUIDE-ITエコーサブ解析]:NT-proBNPガイド治療12カ月で、通常治療に比べ、EF、左室容量とも有意改善認めず】 JACC HF https://t.co/PgZxWpO15t
RT @coconnormd: NT-proBNP Goal Achievement Is Associated With Significant Reverse Remodeling and Improved Clinical Outcomes in HFrEF | JACC…
RT @coconnormd: NT-proBNP Goal Achievement Is Associated With Significant Reverse Remodeling and Improved Clinical Outcomes in HFrEF | JACC…
RT @coconnormd: NT-proBNP Goal Achievement Is Associated With Significant Reverse Remodeling and Improved Clinical Outcomes in HFrEF | JACC…
RT @coconnormd: NT-proBNP Goal Achievement Is Associated With Significant Reverse Remodeling and Improved Clinical Outcomes in HFrEF | JACC…
RT @NirUrielMD: Another nice publication on targets to aim for LV remodeling/recovery in HFrEF https://t.co/Q49SHGm5eS
RT @coconnormd: NT-proBNP Goal Achievement Is Associated With Significant Reverse Remodeling and Improved Clinical Outcomes in HFrEF | JACC…
RT @coconnormd: NT-proBNP Goal Achievement Is Associated With Significant Reverse Remodeling and Improved Clinical Outcomes in HFrEF | JACC…
RT @NirUrielMD: Another nice publication on targets to aim for LV remodeling/recovery in HFrEF https://t.co/Q49SHGm5eS
RT @coconnormd: NT-proBNP Goal Achievement Is Associated With Significant Reverse Remodeling and Improved Clinical Outcomes in HFrEF | JACC…
RT @coconnormd: NT-proBNP Goal Achievement Is Associated With Significant Reverse Remodeling and Improved Clinical Outcomes in HFrEF | JACC…
RT @coconnormd: NT-proBNP Goal Achievement Is Associated With Significant Reverse Remodeling and Improved Clinical Outcomes in HFrEF | JACC…
Among patients with HFrEF, lowering NT-proBNP to <1,000 pg/ml by 12 months was associated with significant reverse remodeling and improved outcomes. A greater reduction in NT-proBNP was associated with more extensive reverse remodeling.
RT @coconnormd: NT-proBNP Goal Achievement Is Associated With Significant Reverse Remodeling and Improved Clinical Outcomes in HFrEF | JACC…
RT @JavierdeJuan1: NT-proBNP Goal Achievement Is Associated With Significant Reverse Remodeling and Improved Clinical Outcomes in HFrEF | J…
RT @NirUrielMD: Another nice publication on targets to aim for LV remodeling/recovery in HFrEF https://t.co/Q49SHGm5eS
RT @coconnormd: NT-proBNP Goal Achievement Is Associated With Significant Reverse Remodeling and Improved Clinical Outcomes in HFrEF | JACC…
NT-proBNP Goal Achievement Is Associated With Significant Reverse Remodeling and Improved Clinical Outcomes in HFrEF | JACC: Heart Failure. Objetivo 🔜 NT-proBNP < 1000 https://t.co/a6l3WdbNmm
RT @coconnormd: NT-proBNP Goal Achievement Is Associated With Significant Reverse Remodeling and Improved Clinical Outcomes in HFrEF | JACC…
RT @NirUrielMD: Another nice publication on targets to aim for LV remodeling/recovery in HFrEF https://t.co/Q49SHGm5eS
Another nice publication on targets to aim for LV remodeling/recovery in HFrEF
NT-proBNP Goal Achievement Is Associated With Significant Reverse Remodeling and Improved Clinical Outcomes in HFrEF | JACC: Heart Failure: Can we get GUIDE -IT back on track? https://t.co/5r2oXNUJvY